series-a
Stage
3
Investors
About
Evommune is a clinical-stage biotechnology company developing novel small molecule and biologic therapies. Their focus is on treating inflammatory diseases.
Explore Evommune's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.